Overview of Warfarin Sodium
Warfarin Sodium, identified by the National Drug Code (NDC) 76282-0333, is a medication manufactured and distributed by Exelan Pharmaceuticals Inc. It is an anticoagulant used to prevent and treat blood clots.
Market Context
The pharmaceutical market, particularly for generic drugs like Warfarin Sodium, is influenced by several key factors:
Generic Drug Market
Generic drugs, such as Warfarin Sodium, play a significant role in the pharmaceutical market. These drugs are often cheaper alternatives to brand-name medications, making them more accessible to a wider population. However, the market for generics is highly competitive, with multiple manufacturers producing the same drug, which can drive prices down[3].
Pricing Trends
In recent years, the median price increase for brand-name drugs has been significant, but generic drugs tend to have more stable or decreasing prices due to competition. For instance, the median price increase for brand-name drugs was 13.4% in 2022, but this trend does not typically apply to generic medications[2].
Regulatory Environment
The National Drug Code (NDC) system, managed by the FDA, ensures that each drug product is identified uniquely. This system helps in tracking and regulating drug prices and availability. The NDC for Warfarin Sodium by Exelan Pharmaceuticals Inc. is 76282-0333, which includes the labeler code, product code, and package code[5].
Price Projections
Given the nature of generic drugs, price projections for Warfarin Sodium are likely to remain stable or decrease slightly over time.
Current Pricing
As of the latest available data, the pricing for Warfarin Sodium is not explicitly provided, but it is generally known that generic anticoagulants like Warfarin are relatively inexpensive compared to newer, brand-name medications.
Future Pricing Trends
- Competition: The presence of multiple generic manufacturers for Warfarin Sodium will continue to drive prices down. This competition ensures that the drug remains affordable for patients.
- Regulatory Impact: Any changes in regulatory policies or FDA guidelines could impact pricing, but this is less likely to affect generic drugs significantly.
- Market Demand: The demand for anticoagulants is consistent due to the chronic nature of conditions they treat. This steady demand helps maintain a stable price environment.
Statistical Insights
While specific price data for NDC 76282-0333 is not provided, the overall trend for generic drugs suggests stability. For example, in the NSCLC market, the impact of generics on patented drugs is significant, with generic versions of drugs like Tarceva and Alimta expected to reduce sales of their patented counterparts substantially by 2025[4].
Impact of Patent Expirations and Generic Competition
The life sciences industry is facing a substantial loss of exclusivity due to expiring patents, which is expected to drive interest in generics and biosimilars. This trend is likely to affect the pricing and market dynamics of various drugs, including those like Warfarin Sodium that are already generic.
Example from Other Markets
In the NSCLC market, the patent expiration of drugs like Tarceva and Alimta has led to a significant decrease in their sales, with generic versions capturing a substantial market share. This pattern is indicative of the broader impact of generics on the pharmaceutical market[4].
Industry Outlook
The life sciences industry is poised for significant transformation in 2025, driven by digital advancements and scientific innovations. However, pricing and access to drugs remain significant concerns. Nearly half of the C-suite executives surveyed expect pricing and access to significantly affect their strategies in 2025[3].
Digital Transformation and Innovation
The integration of technologies like gen AI and increased use of data are expected to boost operational efficiencies and drive breakthrough innovations. While these advancements are more relevant to new and innovative therapies, they also underscore the industry's ability to adapt and innovate, which can indirectly influence the market for established generic drugs.
Key Takeaways
- Stable Pricing: The price of Warfarin Sodium (NDC 76282-0333) is likely to remain stable due to its generic status and competitive market.
- Regulatory Compliance: The drug's NDC ensures it meets FDA regulations, which helps in maintaining market stability.
- Market Demand: The consistent demand for anticoagulants ensures a stable market environment.
- Generic Competition: The presence of multiple generic manufacturers keeps prices competitive.
FAQs
What is the NDC for Warfarin Sodium by Exelan Pharmaceuticals Inc.?
The NDC for Warfarin Sodium by Exelan Pharmaceuticals Inc. is 76282-0333.
What factors influence the pricing of generic drugs like Warfarin Sodium?
Pricing is influenced by competition from other generic manufacturers, regulatory environment, and market demand.
How does the patent expiration of other drugs affect the market for Warfarin Sodium?
The patent expiration of other drugs can increase the overall market share of generics, but it does not directly impact the pricing of Warfarin Sodium since it is already a generic drug.
What is the outlook for the life sciences industry in 2025?
The industry is expected to undergo significant transformation driven by digital advancements and scientific innovations, with a focus on personalized medicine and operational efficiencies.
How does digital transformation impact the market for generic drugs?
While digital transformation is more relevant to new and innovative therapies, it indirectly influences the market by enhancing operational efficiencies and driving breakthrough innovations that can affect the broader pharmaceutical landscape.
Sources
- FindACode: EXELAN PHARMACEUTICALS, INC. - List of Drugs - NDC Labeler.
- DrugPatentWatch: Latest drug prices and trends for NDC 00378-2245.
- Deloitte Insights: 2025 life sciences outlook.
- Drug Development: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
- FDA: National Drug Code Database Background Information.
